Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

NCT04491877 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infection

Interventions

BIOLOGICAL: RSV vaccine formulation 1
BIOLOGICAL: RSV vaccine formulation 2
BIOLOGICAL: Placebo

Sponsor

Sanofi Pasteur, a Sanofi Company